These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. Weiss EJ; Bray PF; Tayback M; Schulman SP; Kickler TS; Becker LC; Weiss JL; Gerstenblith G; Goldschmidt-Clermont PJ N Engl J Med; 1996 Apr; 334(17):1090-4. PubMed ID: 8598867 [TBL] [Abstract][Full Text] [Related]
4. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Zotz RB; Winkelmann BR; Nauck M; Giers G; Maruhn-Debowski B; März W; Scharf RE Thromb Haemost; 1998 Apr; 79(4):731-5. PubMed ID: 9569182 [TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. Carter AM; Ossei-Gerning N; Grant PJ N Engl J Med; 1996 Oct; 335(14):1072-3; author reply 1073-4. PubMed ID: 8801457 [No Abstract] [Full Text] [Related]
7. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Herrmann SM; Poirier O; Marques-Vidal P; Evans A; Arveiler D; Luc G; Emmerich J; Cambien F Thromb Haemost; 1997 Jun; 77(6):1179-81. PubMed ID: 9241754 [TBL] [Abstract][Full Text] [Related]
8. Genetic association studies in coronary disease: the cause of GPIIb-IIIa polymorphisms. Green FR; Watkins H Eur Heart J; 1999 May; 20(10):706-8. PubMed ID: 10400499 [No Abstract] [Full Text] [Related]
9. Platelet glycoprotein polymorphism and risk for coronary heart disease. Wu KK; Aleksic N Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S63-5. PubMed ID: 10070822 [No Abstract] [Full Text] [Related]
10. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking. Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015 [TBL] [Abstract][Full Text] [Related]
11. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538 [TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Carter AM; Ossei-Gerning N; Grant PJ Lancet; 1996 Aug; 348(9025):485-6. PubMed ID: 8709822 [No Abstract] [Full Text] [Related]
13. Platelet glycoprotein IIIa PlA polymorphism and Japanese diabetic patients with coronary heart disease. Odawara M; Matsunuma A; Yamashita K Lancet; 1996 Nov; 348(9037):1310. PubMed ID: 8909392 [No Abstract] [Full Text] [Related]
14. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Antman EM Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Garcia-Ribes M; Gonzalez-Lamuño D; Hernandez-Estefania R; Colman T; Pocovi M; Delgado-Rodriguez M; Garcia-Fuentes M; Revuelta JM Thromb Haemost; 1998 Jun; 79(6):1126-9. PubMed ID: 9657436 [TBL] [Abstract][Full Text] [Related]
16. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697 [TBL] [Abstract][Full Text] [Related]
17. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527 [TBL] [Abstract][Full Text] [Related]
18. GPIIb/IIIa polymorphism in patients with myocardial infarction. Auguadro C; Mortara A; Priori SG; Specchia G Acta Cardiol; 2002 Feb; 57(1):32-3. PubMed ID: 11918133 [No Abstract] [Full Text] [Related]
19. Clues to the death of an Olympic champion. Goldschmidt-Clermont PJ; Shear WS; Schwartzberg J; Varga CF; Bray PF Lancet; 1996 Jun; 347(9018):1833. PubMed ID: 8667943 [No Abstract] [Full Text] [Related]
20. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E; N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]